inside the promptly evolving field of oncology exploration, accurate and productive mutation screening is very important for developing qualified therapies. The KRAS products and services Platform performs a pivotal purpose in this landscape by providing complete options for KRAS mutation profiling and analysis. KRAS mutations, located in close to